| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |